RU2008152751A - Соли тримебутина и n-десметилтримебутина - Google Patents

Соли тримебутина и n-десметилтримебутина Download PDF

Info

Publication number
RU2008152751A
RU2008152751A RU2008152751/04A RU2008152751A RU2008152751A RU 2008152751 A RU2008152751 A RU 2008152751A RU 2008152751/04 A RU2008152751/04 A RU 2008152751/04A RU 2008152751 A RU2008152751 A RU 2008152751A RU 2008152751 A RU2008152751 A RU 2008152751A
Authority
RU
Russia
Prior art keywords
compound
nitroargininate
desmethyltrimebutin
trimebutin
visceral pain
Prior art date
Application number
RU2008152751/04A
Other languages
English (en)
Russian (ru)
Inventor
Джон Л. УОЛЛЭЙС (CA)
Джон Л. УОЛЛЭЙС
Джузеппе ЧИРИНО (IT)
Джузеппе ЧИРИНО
Винченцо САНТАГАДА (IT)
Винченцо САНТАГАДА
Джузеппе КАЛЕНДО (IT)
Джузеппе КАЛЕНДО
Original Assignee
Антиб Терапьютикс Инк. (Ca)
Антиб Терапьютикс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Антиб Терапьютикс Инк. (Ca), Антиб Терапьютикс Инк. filed Critical Антиб Терапьютикс Инк. (Ca)
Publication of RU2008152751A publication Critical patent/RU2008152751A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/30Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to nitro or nitroso groups
    • C07C279/32N-nitroguanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C219/22Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/38Amides of thiocarboxylic acids
    • C07C327/48Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2008152751/04A 2006-06-06 2007-06-06 Соли тримебутина и n-десметилтримебутина RU2008152751A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80406706P 2006-06-06 2006-06-06
US60/804,067 2006-06-06

Publications (1)

Publication Number Publication Date
RU2008152751A true RU2008152751A (ru) 2010-07-20

Family

ID=38801016

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008152751/04A RU2008152751A (ru) 2006-06-06 2007-06-06 Соли тримебутина и n-десметилтримебутина

Country Status (10)

Country Link
US (2) US20110144188A1 (https=)
EP (1) EP2024323B1 (https=)
JP (1) JP5421098B2 (https=)
KR (1) KR20090021346A (https=)
CN (1) CN101489986A (https=)
AU (1) AU2007257174B2 (https=)
BR (1) BRPI0712417A2 (https=)
CA (1) CA2653869A1 (https=)
RU (1) RU2008152751A (https=)
WO (1) WO2007140611A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741359B2 (en) * 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
US7932286B2 (en) * 2007-07-31 2011-04-26 Martin Francois Method for treating colonic viscerosensitivity and spasticity
FR2927076B1 (fr) * 2008-01-31 2010-03-26 Oroxcell Derives de 2-amino-2-phenyl-alkanol, leur preparation et les compositions pharmaceutiques qui les contiennent
EP2744487B1 (en) 2011-08-15 2016-10-05 Research Foundation Of The City University Of New York No- and h2s- releasing compounds
IN2014DN08379A (https=) * 2012-03-12 2015-05-08 Gicare Pharma Inc
WO2016044951A1 (en) * 2014-09-25 2016-03-31 The Hospital For Sick Children Compositions and methods for enhancing hair growth, promoting skin regeneration, and wound healing
RU2752086C1 (ru) 2020-04-27 2021-07-22 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новое соединение [2-(диметиламино)-2-фенилбутил]-3,4,5-триметоксибензоата 4-метил-2н-хромен-2-он-7-илсульфат и его применение
CN114916547B (zh) * 2021-12-06 2024-11-15 南京天秾生物技术有限公司 2,6-二氨基-3-甲基己酸作为植物免疫诱抗剂的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2460919A1 (fr) * 1979-07-11 1981-01-30 Prod Synthese Ste Indle Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique
JPS57500432A (https=) * 1980-03-20 1982-03-11
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
CA2204747C (en) 1995-09-08 2009-05-05 Elena Carceller New azo derivatives of 5-aminosalicylic acid
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
WO1998048826A1 (en) * 1997-04-30 1998-11-05 Northwestern University Inhibition of nitric oxide synthase by amino acids and dipeptides
SV2001000242A (es) * 1999-12-23 2001-10-25 Warner Lambert Co Combinacion de trimebutina con un analgesico derivado del opio
EP1110549A1 (en) * 1999-12-23 2001-06-27 Warner-Lambert Company Use of trimebutine for treating pain
EP1296943A1 (fr) * 2000-05-05 2003-04-02 Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (S.C.R.A.S.) Derives d'aminoacides et leur application a titre de medicaments
US6602915B2 (en) * 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
AU2001285489A1 (en) * 2000-08-29 2002-03-13 Nobex Corporation 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
JP2005533101A (ja) * 2002-07-10 2005-11-04 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー アロステリック阻害剤又はマトリックス金属タンパク質分解酵素−13の、セレコキシブでもバルデコキシブでもないシクロオキシゲナーゼ−2の選択的阻害剤との組合せ物
US20040213842A1 (en) * 2003-01-30 2004-10-28 Dynogen Pharmaceuticals, Inc. Methods of treating gastrointestinal tract disorders using sodium channel modulators
EP1645288A1 (en) 2004-10-07 2006-04-12 CTG Pharma S.r.l. New nuclear transcription factors regulators

Also Published As

Publication number Publication date
US20070275905A1 (en) 2007-11-29
EP2024323B1 (en) 2013-03-27
EP2024323A1 (en) 2009-02-18
EP2024323A4 (en) 2010-07-28
WO2007140611A1 (en) 2007-12-13
AU2007257174B2 (en) 2012-07-12
KR20090021346A (ko) 2009-03-03
BRPI0712417A2 (pt) 2012-09-04
JP2009539777A (ja) 2009-11-19
US20110144188A1 (en) 2011-06-16
JP5421098B2 (ja) 2014-02-19
AU2007257174A1 (en) 2007-12-13
CN101489986A (zh) 2009-07-22
US7666907B2 (en) 2010-02-23
CA2653869A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
RU2008152751A (ru) Соли тримебутина и n-десметилтримебутина
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
RU2382026C2 (ru) Аналоги липоксина а4
UA109774C2 (uk) Кристалічні форми саксагліптину та процес його одержання (варіанти)
RU2013155586A (ru) [1,3]оксазины
RU2009135621A (ru) Хинолиновые производные для лечения воспалительных заболеваний
RU2012118974A (ru) Комбинации ингибитора pi3k и ингибитора мек
RU2013137452A (ru) Композиции, содержащие расщепляемое ферментами пролекарство оксикодона
RU2002101723A (ru) Инданилзамещенные бензолкарбонамиды, способ их получения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
RU2013121788A (ru) Ингибиторы репликации вич
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
RU2012150108A (ru) Аналоги глюкагоноподобного пептида-1 и их применение
JP2010505865A5 (https=)
RU2014112108A (ru) Составы с производными децитабина
EP3404029A3 (en) Pyrimido-pyridazinone compounds and methods and use thereof
RU2009104764A (ru) Производные пурина, как антангонисты a2a
RU2011113967A (ru) Новое производное простагландина i2
RU2010147832A (ru) Диэфирные пролекарства налмефена
RU2008142527A (ru) Производные бупренорфина и их применение
RU2012135698A (ru) Способ и композиция
RU2008108516A (ru) 3,11b-ЦИС-ДИГИДРОТЕТРАБЕНАЗИН ДЛЯ ЛЕЧЕНИЯ ПРОЛИФЕРАТИВНОГО ЗАБОЛЕВАНИЯ ИЛИ ВОСПАЛЕНИЯ
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
RU2013136895A (ru) Новое бициклическое соединение или его соль
JP2011046708A5 (https=)